Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI) (Q33347560)
Jump to navigation
Jump to search
scientific article published on May 1, 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI) |
scientific article published on May 1, 2003 |
Statements
1 reference
Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI) (English)
1 reference
1 reference
Japan Clinical Oncology Group (JCOG) Lung Cancer Study Group
1 reference
I. Sekine
Y. Nishiwaki
K. Noda
S. Kudoh
M. Fukuoka
K. Mori
S. Negoro
A. Yokoyama
K. Matsui
Y. Ohsaki
T. Nakano
1 May 2003
1 reference
1 reference
1 reference
1 reference
14
1 reference
709-714
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference